InvestorsHub Logo
Followers 0
Posts 19
Boards Moderated 0
Alias Born 12/12/2020

Re: None

Saturday, 01/02/2021 11:05:43 AM

Saturday, January 02, 2021 11:05:43 AM

Post# of 84952
So the CEO and Co-Founder HRBM James Gilligan gets announced as an exec Chief Scientific Officer for TRYP Therapeutics in late November 2020, a pharmaceutical company that trades on the Canadian stock exchange for $0.75. 6 weeks later become current and clean. Anyone else see this and have any thoughts. Awkward a CEO of his own company exits to full time gig with another company. Is TRYP a possible merger company.